Wiemer EA - Search Results

1

Application of prolonged microdialysis sampling in carboplatin-treated cancer patients.

Konings IR, Engels FK, Sleijfer S, Verweij J, Wiemer EA, Loos WJ. Konings IR, et al. Among authors: wiemer ea. Cancer Chemother Pharmacol. 2009 Aug;64(3):509-16. doi: 10.1007/s00280-008-0898-0. Epub 2008 Dec 20. Cancer Chemother Pharmacol. 2009. PMID: 19096847 Free PMC article.

2

Chronic imatinib mesylate exposure leads to reduced intracellular drug accumulation by induction of the ABCG2 (BCRP) and ABCB1 (MDR1) drug transport pumps.

Burger H, van Tol H, Brok M, Wiemer EA, de Bruijn EA, Guetens G, de Boeck G, Sparreboom A, Verweij J, Nooter K. Burger H, et al. Among authors: wiemer ea. Cancer Biol Ther. 2005 Jul;4(7):747-52. doi: 10.4161/cbt.4.7.1826. Epub 2005 Jul 9. Cancer Biol Ther. 2005. PMID: 15970668 Free article.

3

Practical aspects of managing gastrointestinal stromal tumors.

Sleijfer S, Seynaeve C, Wiemer E, Verweij J. Sleijfer S, et al. Clin Colorectal Cancer. 2006 Nov;6 Suppl 1:S18-23. doi: 10.3816/ccc.2006.s.003. Clin Colorectal Cancer. 2006. PMID: 17101064 Review.

4

Improved insight into resistance mechanisms to imatinib in gastrointestinal stromal tumors: a basis for novel approaches and individualization of treatment.

Sleijfer S, Wiemer E, Seynaeve C, Verweij J. Sleijfer S, et al. Oncologist. 2007 Jun;12(6):719-26. doi: 10.1634/theoncologist.12-6-719. Oncologist. 2007. PMID: 17602061 Free article.

5

Pitfalls of the application of microdialysis in clinical oncology: controversial findings with docetaxel.

Loos WJ, Zamboni WC, Engels FK, de Bruijn P, Lam MH, de Wit R, Verweij J, Wiemer EA. Loos WJ, et al. Among authors: wiemer ea. J Pharm Biomed Anal. 2007 Oct 18;45(2):288-94. doi: 10.1016/j.jpba.2007.07.023. Epub 2007 Jul 26. J Pharm Biomed Anal. 2007. PMID: 17804188

6

Drug Insight: gastrointestinal stromal tumors (GIST)--the solid tumor model for cancer-specific treatment.

Sleijfer S, Wiemer E, Verweij J. Sleijfer S, et al. Nat Clin Pract Oncol. 2008 Feb;5(2):102-11. doi: 10.1038/ncponc1037. Nat Clin Pract Oncol. 2008. PMID: 18235442 Review.

7

Renal function as a predictor of irinotecan-induced neutropenia.

de Jong FA, van der Bol JM, Mathijssen RH, van Gelder T, Wiemer EA, Sparreboom A, Verweij J. de Jong FA, et al. Among authors: wiemer ea. Clin Pharmacol Ther. 2008 Aug;84(2):254-62. doi: 10.1038/sj.clpt.6100513. Epub 2008 Feb 20. Clin Pharmacol Ther. 2008. PMID: 18288083

8

Dose selection in phase I studies: why we should always go for the top.

Sleijfer S, Wiemer E. Sleijfer S, et al. J Clin Oncol. 2008 Apr 1;26(10):1576-8. doi: 10.1200/JCO.2007.15.5192. Epub 2008 Mar 10. J Clin Oncol. 2008. PMID: 18332465 Review. No abstract available.

9

Editorial: the long and winding road to better cancer cell-specific therapies.

Sleijfer S, Wiemer E. Sleijfer S, et al. Oncologist. 2008 May;13(5):593-5. doi: 10.1634/theoncologist.2008-0090. Oncologist. 2008. PMID: 18515744 Free article. No abstract available.

10

The relevance of microdialysis for clinical on:cology.

Kitzen JJ, Verweij J, Wiemer EA, Loos WJ. Kitzen JJ, et al. Among authors: wiemer ea. Curr Clin Pharmacol. 2006 Sep;1(3):255-63. doi: 10.2174/157488406778249316. Curr Clin Pharmacol. 2006. PMID: 18666750 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

151 results

Search Page

Filters